Post-Merger Nomad Power Seeks Approval for 50.4M Share Issuance, Plan Expansion, and Board Additions
NMAD has more than doubled off its 52-week low of $2.36.
Summary
Nomad Power Solutions' preliminary proxy seeks stockholder approval for a 50.4M share issuance tied to its merger with NOMAD Transportable Power, a 3.5M share increase to its incentive plan, and the election of two new directors. The conversion would dilute existing holders by 64.4% and give former NOMAD shareholders majority control.
Key Events · Corporate Governance and Compliance · NMAD
-
Merger-Related Share Issuance Vote
Stockholders will vote on issuing 50,366,070 shares upon conversion of Series D Preferred Stock, representing 72.6% of pre-merger outstanding shares. Approval removes the Nasdaq Exchange Cap and avoids a 7% annual accruing dividend on the preferred.
-
Massive Dilution for Existing Holders
If all preferred shares convert, existing stockholders' ownership drops to 35.6%, a 64.4% dilution. Former NOMAD shareholders would hold 64.4% of the combined company.
-
Equity Plan Expansion
Proposal to increase the 2020 Stock Incentive Plan by 3.5 million shares, from 3.5 million to 7.0 million total authorized. Only 2.39 million shares remain available for future grants.
-
Board Expansion with NOMAD Nominees
Election of Chris McKay (COO of NOMAD) and Joaquin Aguerre (Director at PowerSecure) to the board, expanding it from seven to nine members and giving NOMAD-affiliated directors greater influence.
Analysis · NMAD · Life Sciences
Following its transformation from Lixte Biotechnology, Nomad Power Solutions is asking stockholders to approve the conversion of 50.4 million shares of Series D Preferred Stock issued in its recent merger with NOMAD Transportable Power Systems. If approved, existing holders face 64.4% dilution, with former NOMAD shareholders gaining majority control. The proxy also seeks to add 3.5 million shares to the equity incentive plan and elect two NOMAD-affiliated directors, cementing the combined entity's governance. Failure to approve the conversion triggers a 7% annual dividend on the preferred stock, adding financial pressure. This vote is the final step in completing the transformative merger that shifted the company from biotech into mobile energy storage.
At the time of this filing, NMAD was trading at $5.79 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $118M. The 52-week trading range was $2.36 to $8.38. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.